Opening book details…
About this Medicine article
Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in Fc RIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma by Forero-Torres, A.; de Vos, S.; Pohlman, B. L.; Pashkevich, M.; Cronier, D. M.; Dang, N. H.; Carpenter, S. P.; Allan, B. W.; Nelson, J. G.; Slapak, C. A.; Smith, M. R.; Link, B. K.; Wooldridge, J. E.; Ganjoo, K. N. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Forero-Torres, A.; de Vos, S.; Pohlman, B. L.; Pashkevich, M.; Cronier, D. M.; Dang, N. H.; Carpenter, S. P.; Allan, B. W.; Nelson, J. G.; Slapak, C. A.; Smith, M. R.; Link, B. K.; Wooldridge, J. E.; Ganjoo, K. N.
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
- Published
- 2012
- Language
- EN
- Field
- Medicine (Health Sciences)